Outlook of Oncology Biosimilars Market Report During 2016-2020
RnRMarketResearch.com adds latest research reports in its collection– Global Oncology Biosimilars Market 2016-2020.
Cancer represents a huge burden on healthcare systems worldwide due to the high cost of treatment therapeutics. The patent expiry of many cancer therapeutics enables the entry of biosimilars into the market. Biosimilars are being incorporated into oncology treatment practices in the supportive care setting. Biosimilars are synthesized with the use of biologic components such as monoclonal antibodies, proteins, hormones, nucleic acids, colony stimulating factors, interleukins, and enzymes.
Complete report available @ http://www.rnrmarketresearch.com/global-oncology-biosimilars-market-2016-2020-market-report.html
The analysts forecast global oncology biosimilars market to grow at a CAGR of 31.76% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global oncology biosimilars market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of biosimilars used to treat cancer.
Inquire on the Report http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=494010
The market is divided into the following segments based on geography: Americas, APAC, EMEA
The report, Global Oncology Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.
Key vendors – Biocon, Celltrion, Dr Reddy’s Laboratories, F Hoffmann-La Roche, Hospira, Mylan, Sandoz
Other prominent vendors – AbbVie, Allergan, Amgen, AstraZeneca, Baxter, Biogen, BioXpress Therapeutics, Boehringer Ingelheim, Cipla, Coherus BioSciences, Coherus BioSciences, Daiichi Sankyo, Emcure Pharmaceuticals, GlaxoSmithKline (GSK), Intas Pharmaceuticals, Merck, Pfizer, Sanofi, 3SBio, and Wockhardt.
Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=494010 (Single User License – US $3000)
Market driver - Rise in number of patent expiries
Market challenge - Risks related to failure of drugs in the market
Market trend - Emergence of biosimilars
Key questions answered in the report include
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the Key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Global biosimilars and oncology biosimilars market 2015
Exhibit 03: Cancer burden in European Union (EU)
Exhibit 04: Global incidence of cancer 2015
Exhibit 05: Global mortality of cancer type 2015
Exhibit 06: Estimated numbers of cancer survivors by age in US 2014
Exhibit 07: Definition of biosimilars in different regions
Exhibit 08: Comparison between biosimilars and generic small molecules
Exhibit 09: Factors influencing biologics and biosimilars
Exhibit 10: Impact of biosimilars cost savings on various sectors
Exhibit 11: Factors affecting success of biosimilars
Exhibit 12: Biosimilars industry: Point-of-view
Exhibit 13: Factors affecting the uptake of biosimilars
Exhibit 14: Strategic factors for new entrant
Exhibit 15: Growth of biosimilars
Read more…
Inquire for Discount on the Report at http://www.rnrmarketresearch.com/contacts/discount?rname=494010
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune – 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]
